A two-dose viral-vectored

Animals Malaria Vaccines / immunology Plasmodium vivax / immunology Malaria, Vivax / prevention & control Mice Genetic Vectors Dependovirus / genetics Female Protozoan Proteins / immunology Antibodies, Protozoan / immunology Disease Models, Animal Vaccinia virus / genetics Humans Mice, Inbred BALB C Immunization, Secondary Vaccine Efficacy
LC16m8Δ Plasmodium vivax PvCSP Pvs25 adeno-associated virus malaria vaccine

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 18 01 2024
accepted: 12 04 2024
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 15 5 2024
Statut: epublish

Résumé

Among

Identifiants

DOI: 10.3389/fimmu.2024.1372584 PMID: 38745665 PMC: PMC11091281
pubmed: 38745665
doi: 10.3389/fimmu.2024.1372584
pmc: PMC11091281
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1372584

Informations de copyright

Copyright © 2024 Yamamoto, Fabbri, Okuhara, Takagi, Kawabata, Katayama, Iyori, Hasyim, Sakamoto, Mizukami, Shida, Lopes and Yoshida.

Déclaration de conflit d'intérêts

Authors SY, HS, HM, and MI are credited as inventors of patents concerning viral-vectored malaria vaccines 2022-24221. HS is also credited as an inventor on a pending patent related to LC16m8Δ WO 2005/054451 A1. However, neither of these products has been brought to market. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Yutaro Yamamoto (Y)

Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.

Camila Fabbri (C)

Instituto Leônidas & Maria Deane/Fiocruz Amazônia, Laboratório de Diagnóstico e Controle e Doenças Infecciosas da Amazônia, Manaus, Amazonas, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Unidade de Pesquisa Clínica Carlos Borborema - UPCCB, Manaus, Amazonas, Brazil.

Daiki Okuhara (D)

Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.

Rina Takagi (R)

Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.

Yuna Kawabata (Y)

Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.

Takuto Katayama (T)

Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.

Mitsuhiro Iyori (M)

Department of Pharmaceutical Sciences, Musashino University, Tokyo, Japan.

Ammar A Hasyim (AA)

Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.

Akihiko Sakamoto (A)

Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.

Hiroaki Mizukami (H)

Division of Genetic Therapeutics, Jichi Medical University, Shimono, Tochigi, Japan.

Hisatoshi Shida (H)

Laboratory of Primate Model, Research Center for Infectious Diseases, Institute for Frontier Life and Medical Science, Kyoto University, Kyoto, Japan.

Stefanie Lopes (S)

Instituto Leônidas & Maria Deane/Fiocruz Amazônia, Laboratório de Diagnóstico e Controle e Doenças Infecciosas da Amazônia, Manaus, Amazonas, Brazil.
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Unidade de Pesquisa Clínica Carlos Borborema - UPCCB, Manaus, Amazonas, Brazil.

Shigeto Yoshida (S)

Laboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › A two-dose viral-vectored
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiprotozoaires › Vaccins contre le paludisme › A two-dose viral-vectored
questionsmedicales.fr › Eucaryotes › Alveolata › Apicomplexa › Haemosporida › Plasmodium › Plasmodium vivax › A two-dose viral-vectored
questionsmedicales.fr › Infection › Maladies vectorielles › Paludisme › Paludisme à Plasmodium vivax › A two-dose viral-vectored
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › A two-dose viral-vectored
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Vecteurs génétiques › A two-dose viral-vectored
questionsmedicales.fr › Virus › Virus à ADN › Parvoviridae › Parvovirinae › Dependovirus › A two-dose viral-vectored
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines de protozoaire › A two-dose viral-vectored
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps antiprotozoaires › A two-dose viral-vectored
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › A two-dose viral-vectored
questionsmedicales.fr › Virus › Virus à ADN › Poxviridae › Chordopoxvirinae › Orthopoxvirus › Virus de la vaccine › A two-dose viral-vectored
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A two-dose viral-vectored
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée BALB C › A two-dose viral-vectored
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Rappel de vaccin › A two-dose viral-vectored
questionsmedicales.fr › Techniques d'investigation › Développement de vaccin › Efficacité vaccinale › A two-dose viral-vectored